tm logo
Trademark Search
XCLEIC

View On IC.GC.CA

XCLEIC
REGISTERED

on 23 Sep 2024

Last Applicant/ Owned by

SEQIRUS INC.

475 Green Oaks ParkwayHolly Springs NC 27540

US

Serial Number

2167081 filed on 28th Oct 2021

Registration Number

TMA1257766 registered on 23rd Sep 2024

Registration expiry Date

28th Oct 2031

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

XCLEIC

Trademark usage description

pharmaceutical research and development; medical research services; biotechnology research, namely, research and development in the medical biotechnol Read More

Classification Information

Class [001]
Medical, biological, and pharmaceutical preparations for scientific, research, medical laboratory use, and for the manufacture of pharmaceuticals, namely, bio-chemical preparations containing messenger RNA for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research and medical research, namely, for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles in form of active chemical ingredients for use in the manufacture of drug delivery pharmaceuticals.

Classification kind code

11

Class [005]
Vaccines for human use; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for preventing and treating of COVID-19, coronavirus disease, and respiratory disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention and treatment of COVID-19, coronavirus disease, and respiratory disorders; lipid nanoparticles for pharmaceutical, medical or diagnostic purposes, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals to treat COVID-19, coronavirus disease, and respiratory disorders; drug carriers for medical use, namely, lipid nanoparticles for delivering drugs; lipid nanoparticles for drug delivery sold as an integral component of drugs; pharmaceutical preparations, namely, messenger RNA and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells.

Classification kind code

11

Class [042]
Pharmaceutical research and development; medical research services; biotechnology research, namely, research and development in the medical biotechnology field; scientific research for medical purposes in the fields of COVID-19, coronavirus disease, and respiratory disorders; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines.

Classification kind code

11

Class [044]
Medical services, namely, conducting of medical examinations; providing medical information in the field of medical treatment services; providing medical information in the field of medical treatment services via a website.

Classification kind code

11

Mark Details

Serial Number

2167081

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 19th Jun 2023		Search Recorded
Submitted for opposition 20
on 19th Jun 2023		Examiner's First Report
Submitted for opposition 223
on 19th Jun 2023		Total Provisional Refusal
Submitted for opposition 256
on 19th Dec 2022		Notification of Possible Opposition Sent
Submitted for opposition 48
on 02th May 2022		Agent Changed
Submitted for opposition 257
on 17th Feb 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 17th Feb 2022		Formalized
Submitted for opposition 1
on 17th Feb 2022		Created
Submitted for opposition 228
on 28th Oct 2021		International Registration
Submitted for opposition 30
on 28th Oct 2021		Filed